# Nina Farrell, Product Lead at Rho Wealth Tech (130 employees) -- read of Portfolio Compass, May 27, 2026

> 9 years in wealth-tech product, currently managing 3 PMs at a B2B fintech that builds tooling for RIAs. Read four Substacks on my train commute and keep a running list of niches I'd go indie in.

## How I got here
Someone in a Slack group I'm in (about 400 ex-wirehouse and fintech-adjacent folks, called Fintech Builders) dropped this link with a note: "anyone seen Wishdeal? they're selling SaaS blueprints for $99." I clicked because wealth management tooling is on my list of niches I'd consider going solo in. I didn't fully understand what I was looking at until about halfway down the page.

## What I clicked first
The headline pushed me away first: "AI That Understands Your Portfolio Better Than You Do." Every advisor I've worked with would read that and close the tab. It talks down to the buyer. I kept reading because the feature descriptions are actually real advisor pain points. Concentration risk clustering. Tax-aware rebalancing. Scenario stress tests. These are things advisors complain about in actual conversations. So I got past the hero.

## Where I paused
The honest disclosure stopped me: "We don't have live customers on this idea yet. We shipped the strategy package; you ship the customer conversations." Up to that point the page reads like a live SaaS product I could sign up for. Then it becomes a blueprint marketplace. Those are two very different things, and switching registers halfway through is disorienting. I had to re-read the pricing section twice to understand I was being sold a $99 build kit, not a subscription tool.

Also the score: "1 in 8 Meaningful-success odds" and "$-25,130 Year-1 take-home." A negative Fermi estimate and 12.5% success odds, right there on the page. That's unusual. I'm not sure if I respect it or if it's the most honest disqualifier I've ever read on a product page.

## What I distrusted
"Tested against $50M+ in real portfolios." I work with RIAs every day. $50M is one decent client relationship. This number sounds specific and grounded, but in the context of who you'd sell this to, it's the floor, not a credential. If it said $2B+ I'd feel differently.

The feature list also reads like a Riskalyze (Nitrogen) or Orion page from 2021: concentration risk, multi-account coordination, scenario stress tests, benchmark decomposition. These exist. The page never says what's different. "Benchmark Clarity" and "Scenario Stress Tests" are menu items at four incumbent vendors. If there's an actual insight about why those tools fall short, it's not here.

And "buyer clarity: 10/10" is the score the studio gave itself. But the page opens talking to what feels like an end investor, pivots to something an RIA would use, then reveals it's actually selling to an entrepreneur who wants to build a tool for RIAs. Those are three different buyers. A 10/10 clarity score on a page that confused me about who it was for is a credibility hit.

## What would convince me
One advisor who specifically left Nitrogen or Orion's portfolio analysis module, with a name, a stated AUM range, and one concrete feature they couldn't get elsewhere. Not a category claim. A displacement story.

The tax-aware rebalancing piece is the most interesting claim on the page. Show an actual anonymized calculation: client had $X unrealized gains, here's the naive rebalancing plan, here's the tax-aware plan, here's what they saved. That specific, that concrete. Right now "Tax-Aware Rebalancing... minimizing what you owe the IRS" is a promise with nothing behind it.

## What I'd ask in an email reply
1. "Distribution ease: 3/10" is your own score. Selling into RIAs means compliance reviews, custodian approval processes, and sales cycles that run 12 to 18 months. What's the specific path to the first 10 customers, and does the $99 kit address that at all?
2. If I buy the $99 build starter, so can 50 other people. What stops this from being a commodity race against everyone else who bought the same kit? Is differentiation supposed to come from my positioning, or is there something in the code that's genuinely proprietary?
3. The hero copy would make most financial advisors roll their eyes. Was it written for advisors, or for an individual investor? Who is the actual end buyer for the product I'd be building?

## Verdict: on-the-fence
The transparency about negative-year-one economics and long odds is genuinely unusual and earns some credibility. But "distribution ease: 3/10" in a space that requires compliance signoff and long enterprise cycles is not a footnote, it's the whole obstacle. I'd pay $5 for the dossier to see if there's a specific go-to-market angle that justifies the bet. I would not pay $99 without that.

---
*Memo by skeptic persona, generated 2026-05-27. Studio breaks own self-grading loop.*